These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22669535)

  • 1. Endothelial dysfunction as an underlying pathophysiological condition of chronic kidney disease.
    Satoh M
    Clin Exp Nephrol; 2012 Aug; 16(4):518-21. PubMed ID: 22669535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Vascular Endothelium in Chronic Kidney Disease: A Novel Target for Aerobic Exercise.
    Martens CR; Kirkman DL; Edwards DG
    Exerc Sport Sci Rev; 2016 Jan; 44(1):12-9. PubMed ID: 26509484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of endothelial dysfunction in chronic kidney disease.
    Malyszko J
    Clin Chim Acta; 2010 Oct; 411(19-20):1412-20. PubMed ID: 20598675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress and endothelial dysfunction in chronic kidney disease.
    Costa-Hong V; Bortolotto LA; Jorgetti V; Consolim-Colombo F; Krieger EM; Lima JJ
    Arq Bras Cardiol; 2009 May; 92(5):381-6, 398-403, 413-8. PubMed ID: 19629295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial vasomotor dysfunction in the brachial artery predicts the short-term development of early stage renal dysfunction in patients with coronary artery disease.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Sano K; Kobayashi T; Fujioka D; Saito Y; Yano T; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Int J Cardiol; 2011 Apr; 148(2):183-8. PubMed ID: 19945185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of endothelial dysfunction in the progression mechanisms of non-alcoholic steatohepatitis in patients with obesity and chronic kidney disease.
    Khukhlina OS; Antoniv AA; Mandryk OY; Smandych VS; Matushchak MR
    Wiad Lek; 2019; 72(4):523-526. PubMed ID: 31055525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part I: General mechanisms: a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and The Japanese Society of Hypertension.
    Rossi GP; Seccia TM; Barton M; Danser AHJ; de Leeuw PW; Dhaun N; Rizzoni D; Rossignol P; Ruilope LM; van den Meiracker AH; Ito S; Hasebe N; Webb DJ
    J Hypertens; 2018 Mar; 36(3):451-461. PubMed ID: 29120962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired L-arginine uptake but not arginase contributes to endothelial dysfunction in rats with chronic kidney disease.
    Martens CR; Kuczmarski JM; Lennon-Edwards S; Edwards DG
    J Cardiovasc Pharmacol; 2014 Jan; 63(1):40-8. PubMed ID: 24084210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Endothelial and Microvascular Function in CKD: Older and Newer Techniques, Associated Risk Factors, and Relations with Outcomes.
    Theodorakopoulou MP; Schoina M; Sarafidis P
    Am J Nephrol; 2020; 51(12):931-949. PubMed ID: 33311014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation.
    Ter Maaten JM; Damman K; Verhaar MC; Paulus WJ; Duncker DJ; Cheng C; van Heerebeek L; Hillege HL; Lam CS; Navis G; Voors AA
    Eur J Heart Fail; 2016 Jun; 18(6):588-98. PubMed ID: 26861140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction and angiogenesis in autosomal dominant polycystic kidney disease.
    Fick-Brosnahan GM
    Curr Hypertens Rev; 2013 Feb; 9(1):32-6. PubMed ID: 23971642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture).
    Félétou M; Vanhoutte PM
    Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H985-1002. PubMed ID: 16632549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction in chronic kidney disease: determinant of susceptibility to end-organ damage and therapeutic response.
    Ochodnicky P; Vettoretti S; Henning RH; Buikema H; Van Dokkum RP; de Zeeuw D
    J Nephrol; 2006; 19(3):246-58. PubMed ID: 16874683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress and vascular inflammation in aging.
    El Assar M; Angulo J; Rodríguez-Mañas L
    Free Radic Biol Med; 2013 Dec; 65():380-401. PubMed ID: 23851032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microvascular endothelial dysfunction is associated with albuminuria and CKD in older adults.
    Seliger SL; Salimi S; Pierre V; Giffuni J; Katzel L; Parsa A
    BMC Nephrol; 2016 Jul; 17(1):82. PubMed ID: 27412615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum gamma-glutamyltransferase levels are inversely related to endothelial function in chronic kidney disease.
    Yilmaz MI; Turgut F; Kanbay M; Saglam M; Sonmez A; Yaman H; Demirbas S; Unal HU; Gok M; Karaman M; Ay SA; Demirkaya E; Covic A; Carrero JJ
    Int Urol Nephrol; 2013 Aug; 45(4):1071-8. PubMed ID: 23242503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of paricalcitol on endothelial function and inflammation in type 2 diabetes and chronic kidney disease.
    Thethi TK; Bajwa MA; Ghanim H; Jo C; Weir M; Goldfine AB; Umpierrez G; Desouza C; Dandona P; Fang-Hollingsworth Y; Raghavan V; Fonseca VA
    J Diabetes Complications; 2015 Apr; 29(3):433-7. PubMed ID: 25633573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance, inflammation, and blood pressure determine vascular dysfunction in CKD.
    Dogra G; Irish A; Chan D; Watts G
    Am J Kidney Dis; 2006 Dec; 48(6):926-34. PubMed ID: 17162147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial Dysfunction by Flow-Mediated Vasodilatation in Chronic Kidney Disease.
    Shukla V; Dey R; Chandra A; Karoli R; Khanduri S
    J Assoc Physicians India; 2015 Jun; 63(6):30-3. PubMed ID: 26710397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential impact of peripheral endothelial dysfunction on subsequent cardiovascular events following percutaneous coronary intervention between chronic kidney disease (CKD) and non-CKD patients.
    Tabata N; Hokimoto S; Akasaka T; Arima Y; Sakamoto K; Yamamoto E; Tsujita K; Izumiya Y; Yamamuro M; Kojima S; Kaikita K; Ogawa H
    Heart Vessels; 2016 Jul; 31(7):1038-44. PubMed ID: 26164597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.